Navigation Links
Steve Fisher joins American Health IT LLC as VP of Operations
Date:5/24/2012

PORTLAND, Maine and SARASOTA, Fla., May 24, 2012 /PRNewswire-iReach/ -- American Health IT LLC announced this week that Steve Fisher has joinedAmerican Health IT LLC as the company's Vice President of Operations.

Larry Gusto, American Health IT's CEO explained that Mr. Fisher's extensive experience in the health technology industry will greatly increase the company's ability to meet rising client demand, adding, "Steve's history with industry leading firms such as IDX, Arthur Andersen and more recently with the University of South Florida's Physicians Group and HealthPoint Medical Group makes him an invaluable addition to our team".

Founded in 2004,American Health IT provides software and services to healthcare organizations in support of electronic health record (EHR) systems and processes.  The company specializes in helping clients extract the maximum clinical and financial values from their EHR systems.

For more information please contact:

Larry Gusto, CEO

American Health IT LLC

950 S. Tamiami Trail, Suite 204

Sarasota, Florida 34236
(941)240-0103  ext 100


Media Contact: Matthew Gusto American Health IT, LLC, 207 356 6164, matt.gusto@amhitech.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE American Health IT, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology news :

1. Stevens awarded $1M for advanced biofuels research
2. Stevens strengthens Dominican Republics Early Warning System for Inundations
3. Stevens receives $25,000 grant from the Engineering Information Foundation
4. Stevens Center for Science Writings presents: Ravens at the Feast, with Bernd Heinrich, April 1
5. Stevens hosts Green Building: The Bottom Line, April 8
6. Stevens to host 2009 N.J. Inventors Hall of Fame Dinner
7. First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4
8. Stevens team wins First Place in ISPE Student Poster Competition
9. Stevens and TNO to collaborate on maritime security
10. Prof. Xiaoguang Meng receives honorary master of engineering from Stevens
11. Nanowire research at Stevens makes cover of Applied Physics Letters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The company's Fingerprint ... ... Multi-Biometric supplier: The company's Fingerprint Identification System is part of an efficient ...
(Date:11/21/2016)... VILNIUS, Lithuania , Nov. 21, 2016 /PRNewswire/ ... identification and object recognition technologies, today announced that ... for smart cards was submitted for the ... and successfully passed all the mandatory steps of ... III evaluation is a continuing test of fingerprint ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , ... December 08, 2016 , ... ... FrontPanel SDK that provide essential device-to-computer interconnect using USB or PCI Express, announced ... FrontPanel support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module that fits a ...
(Date:12/8/2016)... , ... December 08, 2016 ... ... the commercial launch of flexible packaging for their exceptionally efficient human mesenchymal ... system extends RoosterBio’s portfolio of bioprocess media products engineered to radically streamline ...
(Date:12/8/2016)... Fla. , Dec. 8, 2016  HedgePath ... company that discovers, develops and plans to commercialize ... its shares of common stock were approved for ... will begin trading on the OTCQX, effective today, ... qualify for the OTCQX market, companies must meet ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... its phase I/II dose escalation and expansion clinical trial for its lead drug ... Austria. The purpose of the trial was to determine the safety, antitumor activity, ...
Breaking Biology Technology: